You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin, Long-Acting

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Praha 7, Bratislava (Insulin icodec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • Praha 7, Czechia
  • +1 more
Nov 4, 2022

Long Acting Insulin in Control of Gestational Diabetes Trial in Cairo (Long acting insulin, multiple dose regimen)

Completed
  • Long Acting Insulin in Control of Gestational Diabetes Mellitus
  • Long acting insulin
  • multiple dose regimen
  • Cairo, Egypt
    Ain Shams University Maternity Hospital
Sep 4, 2021

Chronic Kidney Diseases Trial in Cairo (Glargine, normal saline)

Recruiting
  • Chronic Kidney Diseases
  • Cairo, Egypt
    Ain Shams University
Jun 6, 2022

Diabetes Trial in Aurora (Detemir)

Completed
Has Results
  • Diabetes
  • Aurora, Colorado
    University of Colorado Denver
Nov 8, 2021

Diabetes, Type 2 Trial in Beijing (insulin icodec)

Completed
  • Diabetes Mellitus, Type 2
  • insulin icodec
  • Beijing, Beijing, China
    Novo Nordisk Investigational Site
Jun 6, 2022

Diabetes, Type 2 Trial in United States (Insulin icodec)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • Los Angeles, California
  • +10 more
Mar 17, 2023

Diabetes, Type 1 Diabetes Trial in Atlanta (Rapid-Acting Insulin, Long acting insulin)

Completed
Has Results
  • Diabetes Mellitus
  • Type 1 Diabetes
  • Rapid-Acting Insulin
  • Long acting insulin
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Sep 2, 2021

Type 1 Diabetes Trial in Bronx (Exenatide, Rapid and long acting insulin, long acting insulin + rapid acting + 1.25 mcg

Completed
Has Results
  • Type 1 Diabetes
  • Bronx, New York
    Albert Einstein CRC- West Campus
Jul 13, 2021

Diabetes, Type 2 Trial in Minneapolis, Berlin, Toronto (4 mm x 32G pen needle (Nano), 8mm x 31G pen needle (Short))

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • 4 mm x 32G pen needle (Nano)
  • 8mm x 31G pen needle (Short)
  • Minneapolis, Minnesota
  • +2 more
Feb 28, 2022

Type 1 Diabetes With Hypoglycemia, type1diabetes Trial in Cairo (Degludec, Glargine, NPH insulin)

Recruiting
  • Type 1 Diabetes Mellitus With Hypoglycemia
  • type1diabetes
  • Cairo, Egypt
    Ain Shams University
Feb 12, 2021

Quality of Life, Clinical Response and Safety of Daily and

Recruiting
  • Growth Hormone Deficiency
  • Growth Hormone Treatment
  • Long-Acting Growth Hormone (LAGH)
  • Minneapolis, Minnesota
    University of Minnesota
Sep 29, 2022

Diabetes Trial in Minneapolis (Degludec, Standard long-acting)

Terminated
  • Diabetes Mellitus
  • Minneapolis, Minnesota
    Hennepin County Medical Center
May 13, 2021

Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

Recruiting
  • Pharmacokinetics
  • Pharmacodynamics
  • Chula Vista, California
    Amphastar Study Site
Sep 13, 2022

Topical Insulin in Neurotrophic Keratopathy After Diabetic

Not yet recruiting
  • Corneal Ulcer
  • +2 more
  • rapid acting insulin
  • BaNHA, Egypt
    Benha University
Jul 2, 2023

Growth Disorders Trial (somavaratan, Daily rhGH)

Completed
Has Results
  • Growth Disorders
  • (no location specified)
Nov 28, 2022

Alzheimer's Disease, Mild Cognitive Impairment Trial in Winston-Salem, Tacoma (Saline, Insulin detemir, Insulin)

Completed
Has Results
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Winston-Salem, North Carolina
  • +1 more
Nov 13, 2020

Type 1 Diabetes Trial in Cambridge (CamAPS FX using faster insulin aspart, CamAPS FX using standard insulin aspart)

Active, not recruiting
  • Type 1 Diabetes Mellitus
  • CamAPS FX using faster insulin aspart
  • CamAPS FX using standard insulin aspart
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Nov 9, 2022

Looking at How Ryzodeg® Works in People With Type 2 Diabetes in

Recruiting
  • Diabetes Mellitus, Type 2
  • Hefei, Anhui, China
  • +50 more
Feb 2, 2023

Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Afrezza
  • +3 more
  • (no location specified)
Jun 6, 2023

Cisgender Female Patients Who Start on Long Acting Cabotegravir

Not yet recruiting
  • Hiv
  • Cabotegravir Injection [Apretude]
  • Orlando, Florida
  • +2 more
Nov 17, 2023

Diabetes, Type 1 Trial in Manchester (FIASP + closed loop device, Insulin aspart (standard of care insulin) + closed loop

Completed
  • Diabetes Mellitus, Type 1
  • FIASP + closed loop device
  • Insulin aspart (standard of care insulin) + closed loop device
  • Manchester, United Kingdom
    Manchester University Hospitals NHS Foundation Trust
Aug 19, 2022

Opioid Use Disorder Trial (naltrexone implant)

Not yet recruiting
  • Opioid Use Disorder
  • naltrexone implant
  • (no location specified)
Dec 7, 2022

Moderate Asthma Trial (Long-Acting Beta Agonist)

Not yet recruiting
  • Moderate Asthma
  • Long-Acting Beta Agonist
  • (no location specified)
Feb 24, 2023

Implementation and Delivery of Cabotegravir Long Acting

Not yet recruiting
  • HIV Infections
  • Cabotegravir Injection [Apretude]
  • Seattle, Washington
  • +1 more
May 16, 2023

Schizophrenia, Schizoaffective Disorder Trial (LYN-005, Risperidone)

Not yet recruiting
  • Schizophrenia
  • Schizoaffective Disorder
  • (no location specified)
Mar 24, 2023